Trials, 22 Trials, Vol 22, Iss 1, Pp 1-9 (2021) Wientjes, M H M, Atiqi, S, Wolbink, G J, Nurmohamed, M T, Boers, M, Rispens, T, de Vries, A, van Vollenhoven, R F, van den Bemt, B J F & den Broeder, A A 2021, ' Using adalimumab serum concentration to choose a subsequent biological DMARD in rheumatoid arthritis patients failing adalimumab treatment (ADDORA-switch) : study protocol for a fully blinded randomised superiority test-treatment trial ', Trials, vol. 22, no. 1, 406, pp. 406 . https://doi.org/10.1186/s13063-021-05358-7 Trials, 22(1):406. BioMed Central Trials, 22, 1 Trials